As health professionals, educating ourselves and community members is one of the best ways to help prevent overdose. Feel free to print and/or circulate any and all of the materials below.
If you have questions about overdose prevention, please email our Indigenous Wellness Team at STBBI@fnha.ca.
Harm reduction aims to meet people where they are at with open arms, acceptance, and compassion - not judgment or shame. Harm reduction recognizes that every life is valuable and that substance use and addiction are complex and challenging.
Take Home Naloxone is a provincial program run through the BC Centre for Disease Control that aims to expand access to naloxone, the opioid overdose reversal drug that prevents overdose death. Physicians and NPs can write prescriptions for Naloxone. With the expansion of this program, Naloxone kits can also be ordered and dispensed by registered nurses to people with past or current opioid use (prescription or non-prescription). It is crucial for community health nurses to be engaged with people who are using drugs; otherwise, this life-saving treatment will not reach those most in need.
To register your community as a Take Home Naloxone site, complete the attached BCTHN New Site Registration Package and fax to (604) 707-2516. If you have any questions about the registration process, email: email@example.com. For additional information on naloxone, follow this link: http://towardtheheart.com/naloxone/
Naloxone Information for Health Professionals (PDF 119 KB)
Take Home Naloxone: Information for New Sites
Harm Reduction & Take Home Naloxone in First Nations Communities
BC Harm Reduction Strategies and Services Policy and Guidelines
Information on Community Naloxone Program for RN non-Certified Practice Implementation – BC CDC Opioid Overdose Prevention Program
Decision Support Tool (DST) for the use of naloxone HCl (Narcan) in the management of suspected opioid overdose in outreach and harm reduction settings
Overdose Data and First Nations in BC Preliminary Findings
Do you have feedback about this page?
There was an error subscribing you. Please try again later.
The email address you entered doesn't appear to be valid. Please try again.
You are now subscribed!